Companies celebrate new stem cell center as an alliance and recruitment catalyst

The recent DKK 2.2bn (USD 330m) grant the Novo Nordisk Foundation has allocated to a center focusing on stem cell treatments has been welcomed with open arms by pharmaceutical companies, who are jostling to enter the field.
by albert rønning andersson, translated by catherine brett and Daniel Frank Christensen

When Novo Nordisk announced that it was investing DKK 2.2bn (USD 330m) in an international stem cell center on Friday, this was music to the ears of many pharmaceutical companies.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading